Clovis raises $130 million IPO
This article was originally published in Scrip
Executive Summary
Clovis Oncology has managed to get its initial public offering away, raising $130 million by selling 10,000,000 shares of its common stock at $13.00 each, the lower range of the filing it made with the US SEC at the start of the month (see: scripintelligence.com, 3 November 2011).